Showing results (41-50 of 135) with videos related to
Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2022
Physiologically Based Pharmacokinetic Modeling of Vitamin D<sub>3</sub> and Metabolites in Vitamin D-Insufficient PatientsColton W Sawyer, Stacey M Tuey, Raymond E West, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 22, 2023
Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoringRaymond E West, Patrick J Oberly, Sharon A Riddler, et al.Kidney International|July 1, 2018
Use of extracorporeal treatments in the management of poisoningsMarc Ghannoum, Robert S Hoffman, Sophie Gosselin, et al.Journal of Toxicology. Clinical Toxicology|December 18, 2003
Stability of atropine sulfate prepared for mass chemical terrorismJackie Dix, Robert J Weber, Reginald F Frye, et al.Journal of Pharmaceutical and Biomedical Analysis|April 4, 2002
Rapid microtiter plate assay for determination of inulin in human plasma and dialysateThomas D Nolin, Ivan V Colaizzi, Paul M Palevsky, et al.The Journal of Pharmacology and Experimental Therapeutics|July 29, 2025
Pharmacokinetic analysis of morphine-3-glucuronide after acute morphine intravenous bolus administration to rats with traumatic brain injuryJonathan Birabaharan, Jeremy Henchir, Sarah Svirsky, et al.Journal of Pharmaceutical and Biomedical Analysis|January 10, 2024
Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoringRaymond E West, Patrick J Oberly, Sharon A Riddler, et al.Clinical Toxicology (Philadelphia, Pa.)|May 8, 2015
Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroupMarc Ghannoum, Martin Laliberté, Thomas D Nolin, et al.Journal of Clinical Pharmacology|December 16, 2014
Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney diseaseMichael A Tortorici, David L Cutler, Anasuya Hazra, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2014
Effect of experimental kidney disease on the functional expression of hepatic reductasesOsama Y Alshogran, Judith Naud, Andrew J Ocque, et al.Pageof 14